Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

PCA3 Testing for the Diagnosis and Management of Prostate Cancer [Internet].

Bradley LA, Palomaki G, Gutman S, Samson DJ, Aronson N.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr.

2.

Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer.

Bradley LA, Palomaki GE, Gutman S, Samson D, Aronson N.

J Urol. 2013 Aug;190(2):389-98. doi: 10.1016/j.juro.2013.02.005. Epub 2013 Mar 29. Review.

PMID:
23545099
3.

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.

Auprich M, Augustin H, Budäus L, Kluth L, Mannweiler S, Shariat SF, Fisch M, Graefen M, Pummer K, Chun FK.

BJU Int. 2012 Jun;109(11):1627-35. doi: 10.1111/j.1464-410X.2011.10584.x. Epub 2011 Sep 21.

4.

Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, Webber E, Perdue LA, Bigler KD, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec.

5.

The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.

Nicholson A, Mahon J, Boland A, Beale S, Dwan K, Fleeman N, Hockenhull J, Dundar Y.

Health Technol Assess. 2015 Oct;19(87):i-xxxi, 1-191. doi: 10.3310/hta19870. Review.

6.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.

7.

Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2010;10(21):1-111. Epub 2010 Dec 1.

8.
9.

Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.

Scattoni V, Lazzeri M, Lughezzani G, De Luca S, Passera R, Bollito E, Randone D, Abdollah F, Capitanio U, Larcher A, Lista G, Gadda GM, Bini V, Montorsi F, Guazzoni G.

J Urol. 2013 Aug;190(2):496-501. doi: 10.1016/j.juro.2013.02.3184. Epub 2013 Mar 1.

PMID:
23466239
10.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B, van der Poel H.

Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25. Review.

PMID:
21871709
11.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

12.

Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2014 Apr;16(4):338-46. doi: 10.1038/gim.2013.141. Epub 2013 Sep 26. Review.

PMID:
24071797
13.

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.

Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S.

BJU Int. 2012 Dec;110(11):1661-5. doi: 10.1111/j.1464-410X.2012.11146.x. Epub 2012 May 4.

14.

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi P, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

15.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
16.

Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.

Archer HA, Smailagic N, John C, Holmes RB, Takwoingi Y, Coulthard EJ, Cullum S.

Cochrane Database Syst Rev. 2015 Jun 23;(6):CD010896. doi: 10.1002/14651858.CD010896.pub2. Review.

PMID:
26102272
17.

Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jul.

18.

Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.

19.

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.

Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C, Kurban L, Lam TB, Padhani AR, Royle J, Scheenen TW, Tassie E.

Health Technol Assess. 2013 May;17(20):vii-xix, 1-281. doi: 10.3310/hta17200. Review.

20.

PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.

Merola R, Tomao L, Antenucci A, Sperduti I, Sentinelli S, Masi S, Mandoj C, Orlandi G, Papalia R, Guaglianone S, Costantini M, Cusumano G, Cigliana G, Ascenzi P, Gallucci M, Conti L.

J Exp Clin Cancer Res. 2015 Feb 6;34:15. doi: 10.1186/s13046-015-0127-8.

Supplemental Content

Support Center